Houston will rebuild! The company that we are featuring will benefit dramatically!

LaPolla Industries,Inc (LPAD) current price .81

LaPolla Industries,Inc. ( LPAD-.81 fully reporting with SEC.)

LPAD is a global supplier and manufacturer of spray polyurethane foam for insulation and roofing applications, reflective roof coating and equipment.

The company is based in Houston, TX. We contacted the company and their 56k foot facility was not harmed by the Hurricane or record flooding that has destroyed or damaged 30k business and residential properties. During our phone call with a spokesperson from the business that the operation would open most likely on Thursday (8/31/2017).

Website: www.lapolla.com 281 219 4700

Financial Data:

First we will look @ the year ending Dec 31, 2016 results

2016

cash---$1.7 million

receivables---$12.5 million

Goodwill and other intangibles ---$6 million

Total assets--$29.3 million

Total liabilities--$19. million

Accumulated Deficit --$84 million--(NOL extremely valuable)

Total Equity---$10.4 million

Rev $86 million vs $78.6 million

Net income $6.4 million vs loss of $577K

Total outstanding shares 124 million- Management controls 85 million shares The balance owned by funds and individuals .

6 months ending June 30, 2017

cash--$561K

Receivables--$14million

Total assets--$28.4 million

Total liabilities --$15.2 million

NOL-$80 million

Stockholders' Equity $13.1 million vs $10.3 million ending Dec 31, 2016

Rev for the six months

$49 million vs $40.7 million june 30, 2016

net income $3.6 million vs $2.5 million

Diluted/sh -----.03--------vs .02--------

fully diluted shares 125 million

During 2017 company declared .01 cash dividend

What is Spray Foam?

Air moves in and out of a home through every hole,crack and crevice. Roughly 33% of air infiltrates through walls, ceiling, and floors. Adding this advanced insulation system is necessary to achieve optimal building performance. Lapolla seals the building envelope to stop conditioned indoor air from escaping and prevent unconditioned air from entering a home.

For damaged homes and business. Retrofit insulation is the answer. See website for greater explanation.

Overview: If this hurricane/tropical storm had not occurred LPAD had begun a rapid rate of growth. The run rate prior to this disaster was around $100 million and net income/sh of around .07 for the Est. year end Dec 31,2017

A game changer has occurred do to this horrible climatic event in South Texas. It is estimated that over 30k homes have been flood and damaged by flood waters. The damage done by Hurricane Harvey is another story and the continuation of this storm continues to move East and severe damage will most definitely continue to ravage personal and business properties.

Lapolla is a one stop shopping for insulation for the whole structure including the roof. The company supplies the equipment, they repair and support the whole operation.

We have seen numbers for the most costly disaster in US history from $100 billion to $160 billion. This number is mind boggling .

In our opinion, this is one of many perfect investments to take advantage of the anticipated building boom that will occur in the Houston and surrounding areas located in South Texas and most likely the East in states that are still in the path of Harvey.

It is our opinion, that LPAD has the potential during next few quarters to see a surge in business that most likely will continue for many years. If LPAD has a revenue base of $100 million with NO climatic event and now we have a $160 billion reconstruction boom that is sure to take hold- the sky is the limit for a company like LPAD! It is very possible that LPAD could easily double or triple their rev stream within a very short period of time and produce dramatic earning growth and continual dividend payments.

The current share price is around .81 and in our opinion the upside potential could easily drive the price into the multiple dollar range as rev and profits grow. In addition the herd is actively looking for investment opportunities that can benefit from the re-building of Houston and surrounding areas damaged by Hurricane Harvey, Tropical storms and Tornadoes created by this weather event.

There are limited "pure" plays to take advantage of this building boom that is going to take place and last for years and LPAD will surely benefit not only for shareholders. The Houston community will take advantage of their technology to rebuilt their homes and businesses. We rate LPAD with our strongest buy rating for short and long term capital gains. We see limited risk on the downside and blue sky on the upside.( Houston needs plenty of blue sky in order to dry itself out so it can start to rebuild).

Stock Performance during past 16 months

SYMBOL***REC PRICE***08/31/17**STATUS

OPXS------------.70------------1.00-------strong B

OPXXW--------.15------------ .30--strong B

VUZI------------$6.35------$6.05--strong B

ESMC---------- .10-----------.12------BUY

STRI-----------.26-------------.16-------- BUY

AETI-----------$1.60---------$1.60----- BUY

WPCS-------$1.25----------$1.25------ BUY

MKRYF-------.10------------.08---------HOLD

BSGM---------$1.33--------$1.35------- BUY

SIMA---------$2.50---------$5.00------BUY-------

ASNB------------.07---------.08----------HOLD---

HEMA-----------.35-------$3.20-----strong B

LUVU------------.055------.055----------BUY

QDLC------------.52--------$1.01--------BUY

VII-----------------.41----------.41------BUY

Note;The best dividend play and favorite warrant investment remains OPXXW. During the next 9 months the company will pay .06/warrant ( .02/quarter) The warrants expire August 2021. The military play OPXS and OPXXW should be owned regardless of the current price since recommendation was made.

We believe that an old favorite of ours ARWR may make a dramatic move during AD mid Sept 2017. Recall they presently have teamed up with AMGN. The stock has been acting very well lately. ARWR currently trading above 200 and 50 day moving average. The recent purchase of KITE by GILD has woken up the remaining Biotech giants and they should become more active this fall by buying promising companies before the other guys buy them. We rate ARWR with a strong Buy rating. Another sleeper-- DXTR around .31 should get their 510k approval from FDA within the next 90 days or less and also are in the final stages of formulating an agreement with Braun for distribution and marketing of their products in Europe.Their MicroCutter 5/80 surgical stapler devices are used for minimally invasive surgical procedures. In the US, surgical staplers are routinely used in more than 1 million minimally invasive laparoscopic, video-assisted or robotic- assisted surgical procedures annually . We like this speculation and believe that this stock could double from current levels.